Company intelligence / Profile preview

Scinai Bioservices

Jerusalem, Israel

Ownership: Private
Development stage: Other

Overview

Scinai Bioservices is a boutique CDMO specializing in biologics process development, analytical methods development, and cGMP manufacturing for early-stage drug projects. Its business is rapidly growing, having recently expanded into the US and signed its first contract with Serpin Pharma for clinical manufacturing. The company maintains a flexible, high-quality offering with regulatory compliance, serving biotech startups globally[2][4][6].

Therapeutic areas: ImmunologyDermatology
Modalities: Recombinant proteinNanobody therapyLiposomal drug delivery
Industry: Contract Manufacturing Organization

Partnerships

Ayana Pharma (liposomal encapsulated drug development services)Max Planck Society (potential NanoAb licensing)University Medical Center Göttingen (potential NanoAb licensing)

Beyond the preview

Go deeper on Scinai Bioservices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scinai Bioservices.

Explore the full profile